Barclays
MTEM

Barclays’s Molecular Templates, Inc. MTEM Stock Holding History

Barclays’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-45
Closed -$30K – 6737
2015
Q3 		$30K Buy
+45
New +$32K ﹤0.01% 5288
2015
Q2 		– Sell
-21
Closed -$14K – 7270
2015
Q1 		$14K Buy
21
+15
+250% +$9.88K ﹤0.01% 6055
2014
Q4 		$3K Hold
6
– – ﹤0.01% 7080
2014
Q3 		$3K Hold
6
– – ﹤0.01% 7346
2014
Q2 		$3K Sell
6
-12
-67% -$7.95K ﹤0.01% 7317
2014
Q1 		$12K Sell
18
-27
-60% -$21.9K ﹤0.01% 6849
2013
Q4 		$30K Sell
45
-26
-37% -$19.6K ﹤0.01% 6496
2013
Q3 		$47K Buy
71
+42
+145% +$34.5K ﹤0.01% 6098
2013
Q2 		$25K Buy
+29
New +$24.5K ﹤0.01% 6728

Barclays's MTEM Position: Q1 2025 in Review

Barclays sold out of Molecular Templates, Inc. (MTEM) in Q1 2025, closing a stake of 102 shares — an estimated $4 sold.

Barclays first reported a position in MTEM in Q2 2013 and held it in 36 quarters. The position peaked at $291K in Q1 2021. 0 funds tracked by Wall St. Rank hold MTEM as of Q1 2025.

  • Barclays reported no remaining Molecular Templates, Inc. position as of Q1 2025 after selling out during the quarter.
  • Barclays sold 102 Molecular Templates, Inc. shares in Q1 2025, an estimated $4.
  • Barclays first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 36 quarters.
  • Barclays's Molecular Templates, Inc. position peaked at $291K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.